BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 107313)

  • 1. Percutaneous nitroglycerin absorption in rats.
    Horhota ST; Fung HL
    J Pharm Sci; 1979 May; 68(5):608-12. PubMed ID: 107313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the method of application on pharmacokinetics of nitroglycerin from ointment in humans.
    Sved S; McLean WM; McGilveray IJ
    J Pharm Sci; 1981 Dec; 70(12):1368-9. PubMed ID: 6798193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nitroglycerin ointments in the rabbit.
    Ritschel WA; Ritschel-Beurlin G; Grummich K
    Arzneimittelforschung; 1980; 30(3):432-5. PubMed ID: 6770874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism.
    Wester RC; Noonan PK; Smeach S; Kosobud L
    J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site dependence for topical absorption of nitroglycerin in rats.
    Horhota ST; Fung HL
    J Pharm Sci; 1978 Sep; 67(9):1345-6. PubMed ID: 99511
    [No Abstract]   [Full Text] [Related]  

  • 6. Gel ointment of verapamil for percutaneous absorption.
    Sekine T; Machida Y; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):245-52. PubMed ID: 3509338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified-release ointment with nitroglycerin β-cyclodextrin inclusion complex for treatment of anal fissures.
    Centkowska K; Sznitowska M
    J Pharm Pharmacol; 2013 Oct; 65(10):1463-72. PubMed ID: 24028613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute toxicity test on dermal application of NT-1 tape and 10% nitroglycerin (NT-1 ointment)].
    Yoshida R; Yamakita O; Shinomiya M; Morita K
    J Toxicol Sci; 1986 May; 11 Suppl 2():1-9. PubMed ID: 3093689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches.
    Chien YW
    Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure.
    Moe G; Armstrong PW
    Am J Med; 1986 Nov; 81(5):765-70. PubMed ID: 3096133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous absorption of 1,3-dinitroglycerin and a trial of pharmacokinetic analysis.
    Ogiso T; Iwaki M; Kanokogi A; Terao Y
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2829-33. PubMed ID: 2127557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.
    McAllister A; Mosberg H; Settlage JA; Steiner JA
    Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous absorption of nitroglycerin.
    Noonan PK; Wester RC
    J Pharm Sci; 1980 Mar; 69(3):365-6. PubMed ID: 6770072
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative controlled skin permeation of nitroglycerin from marketed transdermal delivery systems.
    Chien YW; Keshary PR; Huang YC; Sarpotdar PP
    J Pharm Sci; 1983 Aug; 72(8):968-70. PubMed ID: 6413678
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
    Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vehicles on percutaneous absorption of bucladesine (dibutyryl cyclic AMP) in normal and damaged rat skin.
    Mafune E; Takahashi M; Takasugi N
    Biol Pharm Bull; 1995 Nov; 18(11):1539-43. PubMed ID: 8593475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclic monoterpenes on percutaneous absorption in the case of a water-soluble drug (diclofenac sodium).
    Obata Y; Takayama K; Okabe H; Nagai T
    Drug Des Deliv; 1990 Oct; 6(4):319-28. PubMed ID: 2083031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin.
    Nakashima E; Noonan PK; Benet LZ
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):423-37. PubMed ID: 3119815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroglycerin ointment: application and use.
    Trifiletti P
    Crit Care Nurse; 1982; 2(5):46-8. PubMed ID: 6817969
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis, disposition and pharmacokinetics of nitroglycerin.
    Curry SH; Aburawi SM
    Biopharm Drug Dispos; 1985; 6(3):235-80. PubMed ID: 3929851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.